Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
stem cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an
-
, you will generate and study human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and engineered cardiac tissues (ECTs). You will develop patient-specific cardiac models to identify
-
passionate about stem cells, biomaterials or eye research? Come and join STEM‑CORE and work with cutting‑edge tools like genome editing and in vivo imaging. Become one of fourteen doctoral candidates across
-
-Science include epigenetics, stem-cell and developmental biology, and computational biology. The central research theme is regulation of gene expression during development, both in health and in disease
-
for collecting umbilical cord blood from the operating room and isolating CD34+ stem cells from this blood. Through a culturing process, you will expand and differentiate these CD34+ stem cells into large
-
models using induced pluripotent stem cell (iPSC)-derived kidney organoids. A key aspect of this work will involve integrating bioprinting and organ-on-chip technologies to create mature and
-
cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an affinity
-
mouse embryonic stem cells to allow for rapid protein depletion, mapping transcriptional effects (RNA-seq, TT-seq, PRO-seq), proximity labeling approaches, ChIP, and the bioinformatic analysis
-
culture, imaging). You have proven experience with mammalian cell culture work and are proficient in sterile working techniques. Expertise in stem cell differentiation and other advanced cell culture models
-
contribute directly to this effort by developing patient-specific induced pluripotent stem cell (iPSC)-derived vascular tissues to assess disease severity, drug efficacy and the potential of gene-correction